3D Systems' Solution Enables World's First Facial Implant Manufacturing at Point-of-Care | First 3D-printed PEEK facial implant manufactured at the point-of-care using 3D Systems' EXT 220 MEDPoint-of-care collaboration between surgeons, engineers, and technology enables tailored solutions... ► Artikel lesen |
3D Systems Reports Fourth Quarter and Full Year 2024 Financial Results | ROCK HILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2024. Full-year... ► Artikel lesen |
3D Systems & Daimler Truck | Daimler Buses Innovations Maximize Vehicle Uptime by Decentralizing Spare Part Production | Collaboration between Daimler Truck | Daimler Buses, 3D Systems, Oqton, and Wibu-Systems yields unique remote spare part production solution, protecting Daimler Buses' intellectual property through... ► Artikel lesen |
UltiMaker Unveils the UltiMaker S8, Engineered for Enhanced Productivity and Precision | The UltiMaker S8 delivers up to 4x more productivity and improved part quality, without sacrificing security, reliability or ease of use.
Combined with new materials in the UltiMaker... ► Artikel lesen |
Stratasys Announces Unaudited Preliminary Approximate Fourth Quarter 2024 Financial Results | MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced unaudited preliminary approximate... ► Artikel lesen |
Stratasys Launches TrueDent in Europe, Bringing the Benefits of Monolithic Digital Dentures to Dental Labs, Dentists, and Patients | TrueDent-D resin is now available in major European markets that require CE marking, with strong customer interest already building Stratasys (NASDAQ: SSYS) has declared that its TrueDent-D resin... ► Artikel lesen |
VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market | SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.... ► Artikel lesen |
Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
Organovo, Inc.: Organovo Provides Business Update | SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |